ROSENDALE MARTIN P 4
4 · CYTOMEDIX INC · Filed May 4, 2012
Insider Transaction Report
Form 4
CYTOMEDIX INCCMXI
ROSENDALE MARTIN P
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise of In-Money
Common Stock
2012-05-03$0.54/sh+17,922$9,621→ 150,251 total - Exercise of In-Money
Warrant
2012-05-03−17,922→ 1,076,259 total→ Common Stock (17,922 underlying) - Purchase
Warrant
2012-05-03+4,071→ 1,080,330 totalExercise: $1.42Exp: 2014-12-31→ Common Stock (4,071 underlying)
Footnotes (2)
- [F1]Represents shares of common stock of the Company issued upon exercise of an in-the-money warrant issued in connection with the April 2010 private placement. The exercise price per share of such warrant is $0.5368. The warrant was exercisable immediately and expires on April 9, 2015.
- [F2]30% of the shares of the Company's common stock issuable under the warrant are exercisable immediately on the issuance date, and the remaining portion upon issuance of the last portion of the post-closing consideration to be issued in connection with the February 2012 Aldagen acquisition.